News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,457 Results
Type
Article (39805)
Company Profile (271)
Press Release (655381)
Section
Business (204952)
Career Advice (2018)
Deals (35520)
Drug Delivery (95)
Drug Development (81161)
Employer Resources (169)
FDA (16187)
Job Trends (14885)
News (346190)
Policy (32603)
Tag
Academia (2553)
Alliances (49659)
Alzheimer's disease (1321)
Approvals (16167)
Artificial intelligence (199)
Bankruptcy (359)
Best Places to Work (11660)
Biotechnology (190)
Breast cancer (227)
Cancer (1716)
Cardiovascular disease (128)
Career advice (1681)
CAR-T (123)
Cell therapy (356)
Clinical research (65381)
Collaboration (665)
Compensation (370)
COVID-19 (2582)
C-suite (161)
Data (1630)
Diabetes (213)
Diagnostics (6303)
Earnings (85565)
Employer resources (146)
Events (111368)
Executive appointments (567)
FDA (17087)
Funding (607)
Gene therapy (247)
GLP-1 (656)
Government (4380)
Healthcare (18789)
Infectious disease (2694)
Inflammatory bowel disease (124)
Interviews (310)
IPO (16493)
Job creations (3662)
Job search strategy (1432)
Layoffs (443)
Legal (7920)
Lung cancer (255)
Manufacturing (237)
Medical device (13273)
Medtech (13278)
Mergers & acquisitions (19401)
Metabolic disorders (553)
Neuroscience (1725)
NextGen: Class of 2025 (6546)
Non-profit (4486)
Northern California (2094)
Obesity (309)
Opinion (198)
Patents (162)
People (57155)
Phase I (20377)
Phase II (28813)
Phase III (21436)
Pipeline (711)
Postmarket research (2563)
Preclinical (8607)
Radiopharmaceuticals (241)
Rare diseases (322)
Real estate (5943)
Regulatory (22004)
Research institute (2318)
Resumes & cover letters (350)
Southern California (1799)
Startups (3621)
United States (18490)
Vaccines (615)
Weight loss (211)
Date
Today (92)
Last 7 days (595)
Last 30 days (2620)
Last 365 days (34566)
2025 (4445)
2024 (35337)
2023 (40186)
2022 (51293)
2021 (55841)
2020 (54159)
2019 (46645)
2018 (35124)
2017 (32224)
2016 (31631)
2015 (37709)
2014 (31455)
2013 (26501)
2012 (28770)
2011 (29427)
2010 (27525)
Location
Africa (719)
Arizona (211)
Asia (37719)
Australia (6182)
California (4779)
Canada (1716)
China (393)
Colorado (218)
Connecticut (230)
Europe (80900)
Florida (688)
Georgia (165)
Illinois (458)
Indiana (260)
Maryland (740)
Massachusetts (3614)
Michigan (198)
Minnesota (334)
New Jersey (1349)
New York (1360)
North Carolina (834)
Northern California (2094)
Ohio (175)
Pennsylvania (1100)
South America (1096)
Southern California (1799)
Texas (705)
Utah (143)
Washington State (468)
695,457 Results for "greenlight biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
2024 Ends With Greenlights for Merck’s PAH Drug in UK and BMS’ Opdivo Injection in US
Regulators squeezed in two final approvals before the calendar change with the UK approval of Merck’s Winrevair and the FDA’s greenlight for an injectable formulation of BMS’s cancer blockbuster.
January 2, 2025
·
2 min read
·
Kate Goodwin
Genetown
GreenLight Biosciences Secures EPA Registration for New Bioinsecticide, Calantha, Historic Step Towards A Safer and More Sustainable Food System
GreenLight Biosciences (GreenLight Bio) has been granted registration by the U.S. Environmental Protection Agency (EPA) and several states for its groundbreaking Calantha™ product, designed to target and control the highly destructive Colorado potato beetle.
January 4, 2024
·
5 min read
Deals
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that it is initiating the final steps in closing its previously announced merger with SW MergerCo, Inc. (“Merger Sub”) and SW ParentCo, Inc (“Parent”).
July 20, 2023
·
6 min read
Press Releases
BiVACOR Total Artificial Heart Successfully Implanted in Five Patients as Part of FDA Early Feasibility Study; FDA Greenlights Expansion of the EFS
December 18, 2024
·
3 min read
Deals
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
GreenLight Biosciences Holdings, PBC announced the closing of its previously announced merger with SW MergerCo, Inc. and SW ParentCo, Inc., pursuant to which Merger Sub merged with and into GreenLight with GreenLight surviving as a wholly-owned subsidiary of Parent.
July 24, 2023
·
5 min read
Approvals
Axsome’s Migraine Medicine Clears FDA Bar
The approval of Axsome Therapeutics’ Symbravo for migraine with or without aura came alongside the greenlight for Vertex’s non-opioid treatment Journavx.
January 31, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Arcus Biosciences, Inc. Announces Underwritten Offering of Common Stock
February 18, 2025
·
4 min read
Press Releases
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
February 3, 2025
·
1 min read
Press Releases
BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer
December 2, 2024
·
3 min read
FDA
FDA Approves Vertex’s Journavx as First New Pain Drug in Decades
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum in the fledgling non-opioid pain space.
January 30, 2025
·
4 min read
·
Heather McKenzie
1 of 69,546
Next
